Ares Capital Reports Full-Year 2025 Financial Decline Amidst Active Capital Management and Strong Investment Pipeline
Summary
Ares Capital reported a decline in full-year 2025 EPS and a shift to net unrealized losses, while actively raising capital through equity offerings and maintaining a strong investment backlog.
Key Events
-
Full-Year 2025 Financial Performance Decline
Basic EPS decreased to $1.86 in 2025 from $2.44 in 2024, and net investment income slightly declined. The company also experienced a significant shift from $188 million in net unrealized gains in 2024 to $96 million in net unrealized losses in 2025.
-
Significant Equity Capital Raise in 2025
Ares Capital issued and sold 42.4 million shares of common stock through 'at the market' offerings, generating $937.2 million in gross proceeds during 2025. Approximately $563 million remained available under this program as of year-end.
-
Active Debt Management Post-Year End
In January 2026, the company issued $750 million in 5.250% unsecured notes due 2031 and repaid $1.15 billion in maturing notes, demonstrating ongoing refinancing and debt management.
-
Stock Repurchase Program Extended
The board of directors authorized an amendment in February 2026 to extend the $1.0 billion stock repurchase program until February 15, 2027, providing future flexibility for capital allocation, though no repurchases occurred in 2025.
Analysis
Ares Capital's 2025 annual report reveals a notable decline in financial performance, with basic EPS falling by 23.8% and a significant shift from net unrealized gains to losses year-over-year. This indicates potential challenges in portfolio valuation and profitability. However, the company remains active in managing its capital structure, having issued nearly $1 billion in common stock through at-the-market offerings in 2025 to support its investment activities. The extension of its $1.0 billion share repurchase program and a substantial $2.2 billion investment backlog in early 2026 signal ongoing strategic deployment of capital and a robust pipeline for future growth. Investors should monitor the company's ability to translate its investment pipeline into improved net investment income and realized gains in future periods, especially given the dilutive impact of recent equity raises.
At the time of this filing, ARCC was trading at $19.59 on NASDAQ in the Unknown sector, with a market capitalization of approximately $13.7B. The 52-week trading range was $18.26 to $23.84. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.